Weisi Medical Receives Approval for Pulsed Magnetic Field Device for Abdominal Contouring

Nov 19, 2023 00:10 CST Updated 00:10

VISHEE

Developer, Manufacturer, and Distributor of Rehabilitation Medical Devices

November 9, 2023, NanjingVISHEE(688580.SH) announced that the company has recently received one "Medical Device Registration Certificate" issued by the Jiangsu Provincial Drug Administration. Product name: Pulsed Magnetic Field Therapy Device, Registration CertificateRegistration No.: Su Medical Device Registration Approval 20232091575, Intended Use: Induce muscle contraction by stimulating motor neurons, used for abdominal circumference reduction and body shaping.

As of now,VISHEE Medical hasComprehensive LayoutBody Shaping Magnet, Picosecond Laser, and Radio Frequency(In the fields of privacy, lipolysis, and anti-aging), aiming to meet diverse needs in pelvic floor, women's health, body contouring, and skin across scenarios such as obstetrics and gynecology, dermatology, medical aesthetics, and lifestyle beauty.Sculpting magnets can address needs such as body sculpting and fat reduction; radiofrequency can be used for pelvic floor, anti-aging, and fat dissolution needs; picosecond lasers can achieve functions such as tattoo removal and treatment of skin pigmentation diseases.. It is reported that,Radiofrequency beauty devices refer to products that utilize specific frequencies of radiofrequency currents (typically around 200k-5MHz) or electric fields (typically 13.56 or 40.68MHz) to generate thermal effects on human tissues, aiming to achieve skin tightening, wrinkle reduction, pore contraction, skin firming/lifting, acne treatment, scar treatment, or fat reduction (fat softening or breakdown), among other effects.Radiofrequency DeviceIn addition to acting on the epidermis and dermis layers, it can also affect the collagen fibers in the subcutaneous tissue, tightening the skin. According to the 2022 revised "Regulations on the Supervision and Administration of Medical Devices" by the National Medical Products Administration (NMPA) of China, products such as radiofrequency treatment devices and radiofrequency skin treatment devices are classified as...Class II medical devices are adjusted to Class III medical devices.Since April 1, 2024,Radiofrequency Therapy Devices, Radiofrequency Skin Treatment DevicesProducts that have not been legally registered for a medical device certificate shall not be produced, imported, or sold. However, there is currently a significant gap in China regarding radiofrequency equipment classified as Class III medical devices.

Nanjing Vishee Medical Technology Co., Ltd. was founded inFounded in 2001, VISHEE is a technology innovation-driven enterprise in China's rehabilitation medical device industry, dedicated to providing safe and effective rehabilitation products and comprehensive solutions for professional institutions such as hospitals in细分 fields like pelvic floor and postpartum rehabilitation, neurological rehabilitation, and mental rehabilitation.，InListed on the NEEQ on March 22, 2016。

July 21, 2020，VISHEEOfficially listed on the STAR Market, stock code: 688580. In 2022, the company's operating revenue was 322 million yuan, a year-on-year decrease of 25.21%; net profit attributable to shareholders of the listed company was 93.826 million yuan, a year-on-year decrease of 47.23%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 76.591 million yuan, a year-on-year decrease of 48.99%.

Company products involveMental Rehabilitation, Neurological Rehabilitation, Physical Rehabilitation, and Pelvic FloorAnd postpartum rehabilitation, covering four major fields, involving six major technology platforms: electrophysiology, electrical stimulation, magnetic stimulation, radiofrequency, laser, and rehabilitation robotics. The main products are electrophysiological devices. Rehabilitation medical devices and products such as stimulation devices, magnetic stimulation devices, consumables, and accessories.Terminal sales cover 30 provinces, municipalities, and autonomous regions in China, reaching over 6,000 medical and professional institutions, providing safe and effective rehabilitation products and efficient solutions for these institutions.

The company inRehabilitation Medical FieldA comprehensive solution has been formed in the field of pelvic floor and postpartum rehabilitation, assisting patients in the treatment and training of conditions or symptoms such as urinary incontinence, pelvic organ prolapse, spinal cord injury, and disuse muscle atrophy.Neurological Rehabilitation Field, providing rehabilitation training and treatment for motor, sensory and other functional disorders caused by neurological diseases such as post-stroke sequelae; inMental Rehabilitation Field, used as an adjunctive treatment for symptoms such as low mood, anxiety, insomnia caused by depression, as well as biofeedback therapy for mental disorders or symptoms like ADHD in children.

The company is a technology innovation-driven enterprise in China's rehabilitation medical device industry, possessing advanced technical platforms such as electrical stimulation, magnetic stimulation, and electrophysiology, and mastering relevant core technologies with independent intellectual property rights. To date, it has obtained63 Authorized Patents, owning13 items of Class II medical device products, ParticipateFive major scientific research projects, participated in the formulation of 1 national standard.

December 29, 2020, VISHEE's headquarters R&D economic park project, under the care and support of governments at all levels such as Nanjing City, Yuhuatai District, and Software Valley Management Committee, signed the project investment agreement with a total investment of 500 million RMB,The land transfer was completed on August 10, 2021; official construction began on April 29, 2022, and it was included in Nanjing's major socioeconomic development projects plan for 2022; the pouring of the zero-level structure was completed on April 28, 2023.

It is reported that,VISHEE Medical Headquarters R&D Economic ParkThe land area is nearly 24,000 square meters, with a total construction area of nearly 70,000 square meters. The building adopts the design concept of an "enterprise island," where the "island" symbolizes the harmonious unity of internal landscape and external nature. The building's functions are arranged along the land contour, enclosing courtyards to form the "island" structure. A multi-story atrium is set inside the "island" as the center for exhibition and communication.

October 25, 2023VISHEE Discloses Q3 2023 Report: Revenue in the First Three Quarters of 2023 Reached 330 Million Yuan, a Year-on-Year Increase of 53.19%; Net Profit Attributable to Shareholders of Listed Companies was 102 Million Yuan, a Year-on-Year Increase of 63.56%.

Medbelove Focuses on the Medical Aesthetics Field, Using Industry Trends and Policy Regulations as Entry Points. It Places Emphasis on New Materials, Technologies, and Products in Medical Aesthetics, Providing Authoritative Policy Interpretations, Real-Time Cutting-Edge Information, and Professional Science Popularization Services for Medical Aesthetics Practitioners.